Prospective randomized study of surgical morbidity following primary systemic therapy for breast cancer
β Scribed by Mr P. Forouhi; J. M. Dixon; R. C. F. Leonard; U. Chetty
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 457 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Hepatocellular carcinoma (HCC) recurrence after ablation therapy for primary tumors is common. ## METHODS To evaluate the effectiveness of interferonβalpha (IFNβΞ±) in preventing HCC recurrence, 30 eligible patients were randomized into three groups: 11 patients treated
## Background: Disruption of the lymphatic circulation through breast carcinoma-associated axillary lymph node dissection, with or without radiation therapy, reportedly is the most common cause of lymphedema in developed countries. there is no cure for breast carcinoma-associated lymphedema. althou